These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 20370907)

  • 21. Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen.
    Kato H; Hagihara M; Hirai J; Sakanashi D; Suematsu H; Nishiyama N; Koizumi Y; Yamagishi Y; Matsuura K; Mikamo H
    Drugs R D; 2017 Mar; 17(1):177-187. PubMed ID: 28063020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
    Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
    J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic drug monitoring of amikacin in septic patients.
    Duszynska W; Taccone FS; Hurkacz M; Kowalska-Krochmal B; Wiela-Hojeńska A; Kübler A
    Crit Care; 2013 Jul; 17(4):R165. PubMed ID: 23886243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of an amikacin loading dose for nosocomial infections in very low birthweight infants.
    Berger A; Kretzer V; Gludovatz P; Heinze G; Haiden N; Pollak A
    Acta Paediatr; 2004 Mar; 93(3):356-60. PubMed ID: 15124839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock.
    Allou N; Bouteau A; Allyn J; Snauwaert A; Valance D; Jabot J; Bouchet B; Galliot R; Corradi L; Montravers P; Augustin P
    Ann Intensive Care; 2016 Dec; 6(1):106. PubMed ID: 27807818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
    Delattre IK; Musuamba FT; Nyberg J; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq PE
    Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amikacin pharmacokinetics and the effects of ambient temperature on the dosage regimen in ball pythons (Python regius).
    Johnson JH; Jensen JM; Brumbaugh GW; Boothe DM
    J Zoo Wildl Med; 1997 Mar; 28(1):80-8. PubMed ID: 9226620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic drug monitoring of vancomycin in severe sepsis and septic shock.
    Vázquez M; Fagiolino P; Boronat A; Buroni M; Maldonado C
    Int J Clin Pharmacol Ther; 2008 Mar; 46(3):140-5. PubMed ID: 18397685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic analysis of amikacin twice and single daily dosage in immunocompromised pediatric patients.
    Krivoy N; Postovsky S; Elhasid R; Ben Arush MW
    Infection; 1998; 26(6):396-8. PubMed ID: 9861567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations.
    Roger C; Nucci B; Molinari N; Bastide S; Saissi G; Pradel G; Barbar S; Aubert C; Lloret S; Elotmani L; Polge A; Lefrant JY; Roberts JA; Muller L
    Int J Antimicrob Agents; 2015 Jul; 46(1):21-7. PubMed ID: 25857948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.
    Smits A; De Cock RF; Allegaert K; Vanhaesebrouck S; Danhof M; Knibbe CA
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6344-51. PubMed ID: 26248375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey.
    Fielding RM; Moon-McDermott L; Lewis RO; Horner MJ
    Antimicrob Agents Chemother; 1999 Mar; 43(3):503-9. PubMed ID: 10049258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the Effects of a High Amikacin Dose on Plasma Peak Concentration in Critically Ill Children.
    Medjebeur Hanna R; Levy M; Bille E; Hennequin C; Lesage F; Naudin J; Moulin F; Blanquer M; Béranger A; Renolleau S; Oualha M; Genuini M
    Paediatr Drugs; 2021 Jul; 23(4):395-401. PubMed ID: 34142330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacokinetics of amikacin in Greyhound and Beagle dogs.
    KuKanich B; Coetzee JF
    J Vet Pharmacol Ther; 2008 Apr; 31(2):102-7. PubMed ID: 18307501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis.
    Sherwin CM; Svahn S; Van der Linden A; Broadbent RS; Medlicott NJ; Reith DM
    Eur J Clin Pharmacol; 2009 Jul; 65(7):705-13. PubMed ID: 19305985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic variability of amikacin after once-daily and twice-daily dosing regimen in full-term neonates.
    Vučićević K; Rakonjac Z; Miljković B; Janković B; Prostran M
    J Pharmacol Sci; 2014; 124(2):138-43. PubMed ID: 24441865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Retrospective Review of the Efficiency of First-Dose Therapeutic Drug Monitoring of Gentamicin, Amikacin, and Vancomycin in the Pediatric Population.
    Lim WXS; Chua WBB; Chua JM; Lee Q; Chan JW; Sultana R; Poh BH
    J Clin Pharmacol; 2020 Jan; 60(1):7-15. PubMed ID: 31448430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI investigational eFlow® inline nebulizer system in mechanically ventilated patients.
    Montgomery AB; Vallance S; Abuan T; Tservistas M; Davies A
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):441-8. PubMed ID: 24383962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?
    Heffernan AJ; Germano A; Sime FB; Roberts JA; Kimura E
    Eur J Clin Pharmacol; 2019 Sep; 75(9):1219-1226. PubMed ID: 31154476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of high-dose nebulized amikacin in ventilated critically ill patients.
    Petitcollin A; Dequin PF; Darrouzain F; Vecellio L; Boulain T; Garot D; Paintaud G; Ternant D; Ehrmann S
    J Antimicrob Chemother; 2016 Dec; 71(12):3482-3486. PubMed ID: 27516474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.